SCHEMBL30135261

SCHEMBL30135261

COc1ccc(C=Cc2c(OC)cccc2OC)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 15/20 1.00
CYP1A1 P04798 15/20 1.00
CYP1B1 Q16678 15/20 1.00
NFE2L2 Q16236 2/20 0.67
ALDH1A1 P00352 3/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2C19 P33261 2/20 0.63
MEN1 O00255 2/20 0.63
MAPT P10636 2/20 0.63
KMT2A Q03164 2/20 0.63
CYP2E1 P05181 1/20 0.63
CYP2C8 P10632 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2A6 P11509 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP4B1 P13584 1/20 0.63
CYP2B6 P20813 1/20 0.63
CYP3A5 P20815 1/20 0.63
CYP2A7 P20853 1/20 0.63
CYP3A7 P24462 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25706432 0.87 CYP1A2 (1.00) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL175880 0.84 CYP1A2 (0.89) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL175881 0.84 CYP1A2 (0.89) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL13189258 0.82 CYP1A2 (0.73) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL13169393 0.82 CYP1A2 (0.73) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL21030089 0.80 CYP1A1 (1.00) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL26924044 0.80 CYP1A2 (0.84) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL5498411 0.79 CYP1A2 (1.00) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL5498406 0.79 CYP1A2 (1.00) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL14401250 0.79 CYP1A2 (1.00) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022257986-A1 USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME 广州岐微生物医药科技有限公司 2022-12-15 WO claimed